4.6 Article

StellarPGx: A Nextflow Pipeline for Calling Star Alleles in Cytochrome P450 Genes

期刊

CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 110, 期 3, 页码 741-749

出版社

WILEY
DOI: 10.1002/cpt.2173

关键词

-

资金

  1. GlaxoSmithKline (GSK) Research and Development Ltd
  2. South African National Research Foundation [SFH210111581508, SFH170626244782]

向作者/读者索取更多资源

StellarPGx is a Nextflow pipeline for accurately genotyping CYP genes by combining genome graph-based variant detection and read coverage information. It demonstrated high accuracy and reliability in genotyping CYP genes, especially in complex cases like CYP2D6. The pipeline is open-source and available, showcasing its potential for research and clinical pharmacogenomics applications.
Bioinformatics pipelines for calling star alleles (haplotypes) in cytochrome P450 (CYP) genes are important for the implementation of precision medicine. Genotyping CYP genes using high throughput sequencing data is complicated, e.g., by being highly polymorphic, not to mention the structural variations especially in CYP2D6, CYP2A6, and CYP2B6. Genome graph-based variant detection approaches have been shown to be reliable for genotyping HLA alleles. However, their application to enhancing star allele calling in CYP genes has not been extensively explored. We present StellarPGx, a Nextflow pipeline for accurately genotyping CYP genes by combining genome graph-based variant detection, read coverage information from the original reference-based alignments, and combinatorial diplotype assignments. The implementation of StellarPGx using Nextflow facilitates its portability, reproducibility, and scalability on various user platforms. StellarPGx is currently able to genotype 12 important pharmacogenes belonging to the CYP1, 2, and 3 families. For purposes of validation, we use CYP2D6 as a model gene owing to its high degree of polymorphisms (over 130 star alleles defined to date, including complex structural variants) and clinical importance. We applied StellarPGx and three existing callers to 109 whole genome sequenced samples for which the Genetic Testing Reference Material Coordination Program (GeT-RM) has recently provided consensus truth CYP2D6 diplotypes. StellarPGx had the highest CYP2D6 diplotype concordance (99%) with GeT-RM compared with Cyrius (98%), Aldy (82%), and Stargazer (84%). This exemplifies the high accuracy of StellarPGx and highlights its importance for both research and clinical pharmacogenomics applications. The StellarPGx pipeline is open-source and available from .

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据